Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 364

Results For "NAL"

6627 News Found

Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development
News | May 24, 2023

Lonza launches TheraPEAK T-VIVO cell culture medium to accelerate cell therapy development

Lonza launches the TheraPEAK T-VIVO Cell Culture Medium with a novel chemically defined formulation developed to optimize and streamline CAR T-cell manufacturing


Neutec introduces the oCelloscope automated microbial live-cell imaging technology
News | May 24, 2023

Neutec introduces the oCelloscope automated microbial live-cell imaging technology

The oCelloscope technology is a unique live-cell imaging system for sensitive and detailed monitoring of biological growth and development


Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi
Drug Approval | May 24, 2023

Venus Remedies gets Kenyan GMP certification for its manufacturing facilities in Baddi

The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans


Freenome acquires global immunodiagnostics developer Oncimmune
News | May 23, 2023

Freenome acquires global immunodiagnostics developer Oncimmune

Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection


Roche introduces navify sample tracking for labs to track patient test samples
News | May 23, 2023

Roche introduces navify sample tracking for labs to track patient test samples

navify Sample Tracking is part of the navify Diagnostics portfolio, a set of digital solutions enabling labs to drive end-to-end operational excellence across care settings.


Agilent to appeal patent office decision on CRISPR gRNA patents
News | May 23, 2023

Agilent to appeal patent office decision on CRISPR gRNA patents

Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination


Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr
News | May 22, 2023

Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr

Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023


Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27
Policy | May 22, 2023

Mandaviya to inaugurate conference on 'India Pharma & India Medical Devices’ on May 26-27

8th Edition of the event to promote India as a manufacturing hub of quality medical products in the Pharmaceutical and Medical Devices Sector


Modi addresses 76th session of the World Health Assembly in Geneva virtually
News | May 22, 2023

Modi addresses 76th session of the World Health Assembly in Geneva virtually

India’s efforts are aimed at boosting health at the last mile


Croda signs supply deals with Amyris, BSI for vaccine adjuvants
News | May 21, 2023

Croda signs supply deals with Amyris, BSI for vaccine adjuvants

These announcements are in line with Croda Pharma’s strategy to “Empower Biologics Delivery” and follows news on investments, earlier this year, to expand Croda Pharma’s global manufacturing capabilities to enable the next generation vaccines and therapeutic drugs.